Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy
Abstract Background: Daptomycin is preferred in outpatient parenteral antimicrobial therapy (OPAT) due to daily dosing. Elevations in creatine phosphokinase (CPK) of 3%–10% and musculoskeletal adverse events have been described with daptomycin, but data regarding risk factors and frequency of moni...
Saved in:
| Main Authors: | Meaghen B. Wiley, Kiya K. Bennett, Emily A. Siegrist, Stephen B. Neely, Joseph Sassine, Bryan P. White |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-01-01
|
| Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X25100879/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
by: Matthew Warren Brunke, et al.
Published: (2025-07-01) -
Risk Factors for Hospital Readmission Following Outpatient Parenteral Antimicrobial Therapy (OPAT)
by: Melanie Yousif, et al.
Published: (2025-07-01) -
Outpatient Parenteral Antimicrobial Therapy for Surgery Patients: A Comparison with Previous Standard of Care
by: Anjie Yang, et al.
Published: (2013-01-01) -
Current Perspectives on the Home and Outpatient Use of Parenteral Antibiotics in Canada: An Overview of the Conference
by: H Grant Stiver
Published: (2000-01-01) -
Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity
by: Nagendra N. Mishra, et al.
Published: (2012-01-01)